A Large, Long-Term Disease Registry in Acute Myeloid Leukemia (AML) / Myelodysplastic Syndromes (MDS) Maximizes Patient Enrollment While Minimizing Site Burden
November 17, 2020UBC is currently managing an AML / MDS disease registry for a leading biopharmaceutical client with 200 sites working toward an enrollment target of 2,100 patients...